You are here: Industry Insights > diseases

News List

Bayer, Brigham and Women’s Hospital, and Massachusetts General Hospital open joint lab for research of new treatments for chronic lung diseases worldpharmanews
September 25, 2019
Bayer and Partners HealthCare's founding members Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH) announced the launch of a joint lab to research new drug candidates ...
Higher Risk for Noncommunicable Diseases Seen in Cerebral Palsy drugs
September 04, 2019
Adults with cerebral palsy (CP) have an increased risk for noncommunicable disease, particularly cardiovascular and respiratory disease, according to a study published online in Neurology.
CureVac, Yale Collaborate on Discovery Research contractpharma
August 14, 2019
Will focus on developing novel mRNA-based candidates for pulmonary diseases.
Owlstone Medical explores breath-based testing for more diseases pharmatimes
June 18, 2019
Owlstone Medical has announced that it’s investigating a novel approach to breath-based testing for the onset, progression, and treatment of various diseases.
Evotec to Acquire Just Biotherapeutics in $90M Transaction contractpharma
May 29, 2019
Expands therapeutic offerings in areas such as oncology, CNS, pain, inflammation, metabolics, and infectious diseases.
Single vaccination approach developed to combat respiratory diseases europeanpharmaceuticalreview
May 24, 2019
Scientists have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections.
Scientists advance creation of 'artificial lymph node' to fight cancer, other diseases biospectrumasia
April 21, 2019
Results from a proof-of-principle study in mice demonstrated that a specialized gel that "acts" like a lymph node was able to successfully activate and multiply cancer-fighting immune system T-cells, reported ScienceDaily.
Diseases cost the African Region $2.4 trillion a year: WHO biospectrumasia
April 02, 2019
WHO launches an investment case to achieve SDGs and universal health coverage in Africa
With pivot to less-rare diseases, Alexion needs a new sticker-price plan, CEO says fiercepharma
January 10, 2019
In 2019, Alexion is looking to pivot from an ultrarare-disease company to a rare-disease company—and it knows its pricing strategy has to change.
NUS team invents new diagnostic device biospectrumasia
October 15, 2018
enVision takes between 30 minutes to one hour to detect the presence of diseases, which is two to four times faster than existinginfection diagnostics methods.

Previous page 1 2 Next page